Guanbo Wang | Medicine and Dentistry | Best Researcher Award

Dr. Guanbo Wang | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, United States

Dr. Guanbo Wang is a distinguished postdoctoral research fellow at the CAUSALab, Harvard T.H. Chan School of Public Health. With a robust background in biostatistics and epidemiology, his work primarily focuses on developing innovative statistical methodologies to enhance causal inference in public health research. Dr. Wang’s expertise lies in integrating complex data sources to derive meaningful insights into treatment effects, particularly in the context of randomized clinical trials and observational studies. His interdisciplinary approach combines rigorous statistical theory with practical applications, aiming to inform clinical decision-making and health policy. Throughout his academic and professional journey, Dr. Wang has demonstrated a commitment to advancing public health through methodological innovation and collaborative research.

Professional Profile

Education

Dr. Wang’s academic journey commenced with a Bachelor of Science degree from China Textile University in Shanghai, China, in 1999. He pursued further studies at Shanghai Jiao Tong University, earning a Master of Science in 2002 and a Ph.D. in 2005. His doctoral research laid the foundation for his future endeavors in biostatistics and epidemiology. In 2019, Dr. Wang expanded his academic horizons as a visiting scholar at Harvard University, engaging with leading experts in the field. He culminated his formal education with a Ph.D. in Biostatistics from McGill University in 2022, where he honed his skills in statistical modeling and causal inference. Dr. Wang’s comprehensive educational background equips him with the theoretical knowledge and practical expertise necessary for his contributions to public health research.

Professional Experience

Dr. Wang’s professional experience encompasses a blend of academic research and industry collaboration. From 2015 to 2022, he served as a research assistant at McGill University and the McGill University Health Centre Research Institute, contributing to various projects in biostatistics and epidemiology. His industry experience includes internships and consultancy roles at prominent organizations such as Biogen, Roche, Baker & McKenzie, FINEOS Co., Ltd., KPMG China, and AXA Insurance Group. These roles provided Dr. Wang with practical insights into the application of statistical methods in diverse settings, including pharmaceuticals, legal consulting, and insurance. In 2023, he collaborated with the Center for Biostatistics in AIDS Research (CBAR), further solidifying his expertise in clinical trial analysis. Dr. Wang’s multifaceted professional background reflects his adaptability and commitment to applying statistical methodologies to real-world challenges.

Research Interests

Dr. Wang’s research interests are centered on advancing causal inference methodologies to address complex questions in public health. He focuses on data integration techniques that allow for the extension of causal inferences across different populations and data sources. His work on treatment effect heterogeneity aims to identify subpopulations that may benefit differently from interventions, thereby informing personalized medicine approaches. Dr. Wang also explores innovative trial designs, including adaptive and Bayesian frameworks, to enhance the efficiency and ethical conduct of clinical studies. Additionally, he is interested in incorporating prior knowledge, such as expert opinions, into statistical models to improve their interpretability and relevance. His methodological contributions are applied across various disease areas, including cardiovascular diseases, cancer, infectious diseases, and mental health disorders.

Research Skills

Dr. Wang possesses a comprehensive skill set in statistical methodologies and data analysis. His expertise includes nonparametric and semiparametric statistics, machine learning, high-dimensional data analysis, survival analysis, and optimization techniques. He is proficient in handling complex data structures, such as time-dependent treatments and longitudinal outcomes, commonly encountered in clinical and observational studies. Dr. Wang is adept at utilizing programming languages like R, Python, and C++ for statistical computing and developing analytical tools. His experience spans various data sources, including randomized clinical trials, electronic health records, and administrative databases. This diverse skill set enables him to tackle intricate research questions and contribute to methodological advancements in public health.

Awards and Honors

Dr. Wang’s contributions to biostatistics and public health research have been recognized through numerous awards and honors. He received the Fonds de Recherche du Québec – Santé Doctoral Training Grant (2019-2022), acknowledging his potential in health research. In 2021, he was honored with the Centre de Recherches Mathématiques StatLab Graduate Award and the McGill GREAT Award, reflecting his academic excellence. His achievements also include the McGill Graduate Excellence Award (2016-2021), the McGill Mobility Award (2019), and the McGill University Health Centre Studentship Fellowship (2019). Additionally, he was awarded the Statistical Society of Canada Biostatistics Travel Award in 2018. These accolades underscore Dr. Wang’s dedication to advancing statistical methodologies and their application in public health.

Conclusion

Dr. Guanbo Wang exemplifies a commitment to enhancing public health through methodological innovation in biostatistics and epidemiology. His extensive education and diverse professional experiences have equipped him with a robust foundation to address complex health research questions. Dr. Wang’s research endeavors aim to refine causal inference techniques, improve clinical trial designs, and integrate diverse data sources for comprehensive analyses. His contributions have the potential to inform evidence-based decision-making and personalized healthcare strategies. As he continues his work at the CAUSALab, Dr. Wang remains at the forefront of developing statistical methodologies that bridge the gap between data and impactful public health interventions.

Publications Top Notes

  1. Causal inference with multiple concurrent medications: A comparison of methods and an application in multidrug-resistant tuberculosis
    Authors: A.A. Siddique, M.E. Schnitzer, A. Bahamyirou, G. Wang, T.H. Holtz, G.B. Migliori, et al.
    Journal: Statistical Methods in Medical Research, 28(12), 3534–3549
    Year: 2019
    Citations: 31

  1. Estimating treatment importance in multidrug-resistant tuberculosis using Targeted Learning: An observational individual patient data network meta-analysis
    Authors: G. Wang, M.E. Schnitzer, D. Menzies, P. Viiklepp, T.H. Holtz, A. Benedetti
    Journal: Biometrics, 76(3), 1007–1016
    Year: 2020
    Citations: 17

  2. Using Effect Scores to Characterize Heterogeneity of Treatment Effects
    Authors: G. Wang, P.J. Heagerty, I.J. Dahabreh
    Journal: Journal of the American Medical Association
    Year: 2024
    Citations: 16

  1. Modeling treatment effect modification in multidrug-resistant tuberculosis in an individual patient data meta-analysis
    Authors: Y. Liu, M.E. Schnitzer, G. Wang, E. Kennedy, P. Viiklepp, M.H. Vargas, et al.
    Journal: Statistical Methods in Medical Research, 31(4), 689–705
    Year: 2022
    Citations: 10

  2. Evaluating hybrid controls methodology in early-phase oncology trials: A simulation study based on the MORPHEUS-UC trial
    Authors: G. Wang, M.P. Costello, H. Pang, J. Zhu, H.J. Helms, I. Reyes-Rivera, R.W. Platt, et al.
    Journal: Pharmaceutical Statistics, 23(1), 31–45
    Year: 2023
    Citations: 8

  3. Predictive factors of detectable viral load in HIV-infected patients
    Authors: A. Bouchard, F. Bourdeau, J. Roger, V.T. Taillefer, N.L. Sheehan, M. Schnitzer, G. Wang, et al.
    Journal: AIDS Research and Human Retroviruses, 38(7), 552–560
    Year: 2022
    Citations: 8

  4. Penalized G-estimation for effect modifier selection in the structural nested mean models for repeated outcomes
    Authors: A. Jaman, G. Wang, A. Ertefaie, M. Bally, R. Lévesque, R. Platt, M. Schnitzer
    Journal: Biometrics, 81(1)
    Year: 2024
    Citations: 5

  5. Robust integration of external control data in randomized trials
    Authors: G. Wang, R. Karlsson, J.H. Krijthe, I.J. Dahabreh
    Journal: arXiv preprint, arXiv:2406.17971
    Year: 2024
    Citations: 4

  1. Association between Sitting Time and Urinary Incontinence in the US Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2007 to 2018
    Authors: D. Xingpeng, Y. Chi, X. Liyuan, W. Guanbo, L. Banghua
    Journal: Heliyon, 10(6)
    Year: 2024
    Citations: 4

  1. Integrating complex selection rules into the latent overlapping group Lasso for constructing coherent prediction models
    Authors: G. Wang, S. Perreault, R.W. Platt, R. Wang, M. Dorais, M.E. Schnitzer
    Journal: Statistics in Medicine
    Year: 2025
    Citations: 3

 

Lakovos Nomikos | Health Professions | Outstanding Scientist Award

Prof. Dr. Lakovos Nomikos | Health Professions | Outstanding Scientist Award

MD, PhD, FACS from European University Cyprus Nicosia Cyprus, Rea Maternity Hospital Athens Greece, Greece

Dr. Iakovos N. Nomikos, MD, PhD, FACS, is a distinguished academic surgeon with over four decades of experience in clinical practice, research, and medical education. Born on October 1, 1951, in Greece, Dr. Nomikos has dedicated his career to advancing surgical science, with particular contributions in the fields of transplantation biology, metabolic support for critical illness, and oncologic surgery. He has held significant roles in both academic and hospital settings, including Assistant Professor and Chairman of Surgery at major institutions. His extensive training includes fellowships in the United States and the United Kingdom, reflecting a broad international perspective and collaboration. Dr. Nomikos is a Fellow of the American College of Surgeons and a respected member of multiple medical societies. His work spans a wide range of clinical and research domains, and he is widely recognized for his mentorship, leadership, and commitment to the integration of scientific innovation into surgical practice. His contributions have been presented in international conferences, lectures, and numerous publications in both Greek and English literature. Dr. Nomikos continues to serve as an adjunct professor, influencing the next generation of medical professionals while remaining actively engaged in clinical and academic research.

Professional Profile

Education

Dr. Iakovos N. Nomikos pursued his early education at the “Gymnasium” High School in Syros, Cyclades, Greece, from 1963 to 1969, graduating with excellence. He then entered the Medical School of Athens University, where he studied from 1969 to 1975. His academic record was exemplary, achieving an “excellency” degree. The medical program at Athens University included an integrated internship in the final year, consisting of clinical rotations in internal medicine, surgery, pediatrics, and obstetrics-gynecology. This foundational training provided him with a solid grounding in multiple medical disciplines. Following his medical degree, Dr. Nomikos completed a residency in General Surgery at “Evagelismos” Medical Center in Athens from 1975 to 1980. His postgraduate education continued through prestigious fellowships in surgical nutrition, transplantation biology, critical care, and hepatobiliary surgery at world-renowned institutions such as the University of Colorado Health Sciences Center, New York Medical College, and The Queen Elizabeth Hospital in Birmingham, England. These advanced studies and international experiences significantly enriched his clinical knowledge and research capabilities, positioning him as a leader in surgical education and innovation. His diverse academic training has underpinned a career defined by scientific inquiry, clinical excellence, and global collaboration.

Professional Experience

Dr. Nomikos’s professional career spans several decades, marked by progressive responsibility and distinction in surgical practice and academic leadership. His early career began with positions as an attending surgeon at Evangelismos Medical Center and Larissa General Hospital in Greece. From 1987 to 2004, he served in the Department of Surgery at Tzanion General Hospital, Piraeus, progressing from attending surgeon to associate director. In 2004, he was appointed Chairman of Surgery at Metaxa Cancer Memorial Hospital, where he served until 2018, overseeing clinical operations, research, and resident education. Since 2019, he has continued practicing surgery in the private sector at Rea Maternity Hospital and Metropolitan General Hospital in Athens. In parallel with his clinical duties, Dr. Nomikos has held academic positions, including Lecturer and Assistant Professor of Surgery at Athens University and currently serves as Adjunct Professor of Surgery at the European University of Cyprus. His teaching responsibilities span both the School of Medicine and the Department of Life Sciences. Throughout his career, he has played a vital role in shaping surgical education programs and mentoring young professionals. His leadership has consistently integrated evidence-based practice with clinical innovation, reinforcing his reputation as a pillar of surgical excellence in Greece and beyond.

Research Interests

Dr. Iakovos N. Nomikos has cultivated a robust and diverse research portfolio throughout his career, combining basic science with applied clinical studies. His early research focused on transplantation biology, with particular emphasis on pancreatic islet transplantation for insulin-dependent diabetes mellitus (IDDM), examining graft destruction mechanisms. He has also extensively studied ischemia-reperfusion injury, a critical area in transplantation and trauma surgery. Another major area of interest includes the cellular biology of peritonitis, where he has investigated immune response and inflammation in abdominal infections. In applied research, Dr. Nomikos has addressed practical clinical challenges such as peritoneal infections, neo-adjuvant chemotherapy for solid tumors, metabolic responses in critically ill surgical patients, and functional staging of acute surgical illness. His interest in surgical metabolism and nutrition has informed clinical protocols that improve recovery and outcomes in post-operative and intensive care settings. These research interests not only highlight his interdisciplinary approach but also reflect a commitment to enhancing surgical care through scientific advancement. Dr. Nomikos’s work stands at the intersection of innovation and clinical relevance, aiming to translate laboratory discoveries into improved patient outcomes. His efforts have contributed significantly to the fields of surgical oncology, critical care, and transplant medicine.

Research Skills

Dr. Nomikos brings an exceptional set of research skills developed through decades of clinical practice, international training, and academic scholarship. His expertise spans both bench-side experimentation and bedside clinical research. In basic science, he is skilled in experimental models of islet transplantation, immunological assays, and the study of cellular mechanisms involved in ischemia-reperfusion injury and peritonitis. His training in the United States and the UK equipped him with advanced competencies in surgical research methodologies, including critical care and transplant-related studies. In clinical research, he excels in protocol development, data analysis, clinical trial execution, and outcome evaluation, particularly in surgical oncology and critical care settings. He has led and participated in projects focusing on chemotherapy protocols, surgical metabolic support, and the functional assessment of acute surgical conditions. Dr. Nomikos is also adept at medical writing, scientific presentation, and research mentoring, contributing significantly to academic publications, oral communications, and educational leadership. His ability to bridge theoretical science with surgical practice exemplifies translational research at its best. These multifaceted skills have enabled him to drive innovations in patient care, guide clinical decision-making, and mentor a generation of surgeon-scientists within Greece and internationally.

Awards and Honors

Dr. Iakovos N. Nomikos has received numerous honors and awards in recognition of his exceptional contributions to surgery, research, and education. He is a Fellow of the American College of Surgeons (FACS), a prestigious international credential that signifies excellence in surgical practice and ethics. His career achievements have been acknowledged through several institutional, national, and international recognitions, including leadership positions in major hospitals and academic programs. He has been honored for his work in surgical oncology, critical care, and transplantation science. Dr. Nomikos’s scholarly efforts have been consistently featured in leading international congresses, where he has delivered invited lectures, chaired roundtable discussions, and presented scientific exhibits. His teaching accomplishments have also been recognized by academic institutions where he has played a pivotal role in curriculum development and resident training. Moreover, his influence extends through professional societies, where he holds memberships that reflect both his scientific stature and dedication to interdisciplinary collaboration. These accolades collectively underscore a career marked by lifelong service to advancing surgical science and mentoring future generations of clinicians. His awards affirm his lasting impact on both the academic and medical communities, validating his status as a respected leader in the global surgical field.

Conclusion

Dr. Iakovos N. Nomikos exemplifies the ideal candidate for recognition through a Research for Outstanding Scientist Award. His career is defined by a seamless integration of academic rigor, clinical excellence, and translational research. From pioneering studies in transplantation biology to practical innovations in critical care and oncologic surgery, he has consistently addressed key challenges in surgical practice through scientific inquiry. His mentorship, leadership, and continued contributions as an adjunct professor demonstrate ongoing relevance and impact. With a history of productive research collaborations, international training, and a strong publication and presentation record, Dr. Nomikos has significantly advanced both theoretical and applied surgical knowledge. Although further visibility through recent high-impact publications or patent disclosures could strengthen his profile, the depth, breadth, and longevity of his contributions are clear. He has made lasting advancements in patient care, surgical methodology, and medical education. In conclusion, Dr. Nomikos’s distinguished achievements over several decades merit recognition not only as a leading figure in his field but also as a scientist whose work has tangibly improved lives and enriched the broader medical community. His career is a model of what sustained excellence and dedication in clinical research can accomplish.

Publications Top Notes

  • Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice
    Authors: IN Nomikos, SJ Prowse, P Carotenuto, KJ Lafferty
    Journal: Diabetes, 35(11), 1302–1304
    Citations: 159
    Year: 1986

  • Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation
    Authors: R Omar, I Nomikos, G Piccorelli, J Savino, N Agarwal
    Journal: Gut, 30(4), 510–514
    Citations: 139
    Year: 1989

  • Involvement of O2 radicals in ‘autoimmune’ diabetes
    Authors: IN Nomikos, Y Wang, KJ Lafferty
    Journal: Immunology and Cell Biology, 67(1), 85–87
    Citations: 97
    Year: 1989

  • Washing with or without chloramphenicol in the treatment of peritonitis: a prospective, clinical trial
    Authors: IN Nomikos, K Katsouyanni, AN Papaioannou
    Journal: Surgery, 99(1), 20–25
    Citations: 64
    Year: 1986

  • Effect of cyclosporine on immunologically mediated diabetes in nonobese diabetic mice
    Authors: Y Wang, M McDuffie, IN Nomikos, L Hao, KJ Lafferty
    Journal: Transplantation, 46(2), 101S–106S
    Citations: 49
    Year: 1988

  • Current surgical aspects of palliative treatment for unresectable pancreatic cancer
    Authors: K Karapanos, IN Nomikos
    Journal: Cancers, 3(1), 636–651
    Citations: 28
    Year: 2011

  • Protective and damaging aspects of healing: A review
    Authors: IN Nomikos, C Malizos, NC Vamvakopoulos
    Journal: Wounds: A Compendium of Clinical Research and Practice, 18(7), 177–185
    Citations: 28
    Year: 2006

  • Practical approaches to effective management of intestinal radiation injury: benefit of resectional surgery
    Authors: N Perrakis, E Athanassiou, D Vamvakopoulou, M Kyriazi, H Kappos, …
    Journal: World Journal of Gastroenterology, 17(35), 4013
    Citations: 27
    Year: 2011

  • Carcinoma of the inguinal region arising from endometriosis of the round ligament. Report of a case
    Authors: J Elemenoglou, A Skopelitou, I Nomikos
    Journal: European Journal of Gynaecological Oncology, 14(1), 28–32
    Citations: 27
    Year: 1993

  • Tamoxifen-induced endometrial polyp. A case report and review of the literature
    Authors: IN Nomikos, J Elemenoglou, J Papatheophanis
    Journal: European Journal of Gynaecological Oncology, 392, 2936
    Citations: 23
    Year: 1998

Vanina Taliercio | Health Professions | Best Researcher Award

Assist. Prof. Dr. Vanina Taliercio | Health Professions | Best Researcher Award

Faculty, MD from University of Utah, United States

Dr. Vanina L. Taliercio is a physician-scientist whose career spans clinical practice, research, and academic leadership. Currently an Assistant Professor at the University of Utah, she brings extensive expertise in pediatrics, dermatology, genetics, and biomedical informatics. Her work integrates patient care with research, particularly focusing on genetic conditions, neurofibromatosis (NF), and tuberous sclerosis complex (TSC). Dr. Taliercio holds leadership roles as Co-director of both the NF and TSC clinics and serves as Associate Program Director for medical genetics and pediatrics/genetics programs. Her background includes significant contributions to national health initiatives, such as improving medication distribution systems for Hansen’s Disease in Argentina. In research, she has published several papers and presented at international conferences, particularly in dermatology and health informatics. Dr. Taliercio’s multidisciplinary approach, combining clinical insight with data-driven research, makes her a dynamic and impactful contributor to academic medicine. She is committed to advancing patient care, improving health outcomes, and mentoring the next generation of medical professionals.

Professional Profile

Education

Dr. Vanina Taliercio earned her Doctor of Medicine (MD) degree from Universidad del Salvador, Argentina, in 2002. To deepen her research expertise, she pursued a Master of Science (MS) in Biomedical Informatics at Oregon Health & Science University in 2012. Her postgraduate medical training is extensive and diverse. She completed a pediatrics residency at Pedro de Elizalde Hospital in Buenos Aires from 2003 to 2007, followed by a pediatric dermatology fellowship at Ramos Mejía Hospital from 2012 to 2015. After relocating to the United States, she undertook an ACGME residency in pediatrics at the University of Utah from 2020 to 2021, and most recently completed a medical genetics fellowship at the University of Utah between 2021 and 2023. This broad educational journey has equipped her with a unique combination of clinical and research expertise across multiple disciplines, positioning her well for leadership roles in academic medicine.

Professional Experience

Dr. Taliercio’s professional career spans several important roles in both Argentina and the United States. She began as a pediatrician at Hospital Italiano de Buenos Aires and OSDE, providing care to infants and children. She then worked as a clinical data research analyst, focusing on electronic health records, data reconciliation, and healthcare quality indicators, which led to key publications. At the national level, she contributed to Argentina’s Leprosy National Program, overseeing WHO medication distribution, developing national disease statistics, and creating educational materials to reduce stigma. Since moving to the United States, Dr. Taliercio has served as an Assistant Professor at the University of Utah, providing outpatient and inpatient care for patients with genetic and metabolic conditions. In addition, she co-directs two specialized clinics and supports the development of medical education programs as an Associate Program Director. Her career reflects a commitment to integrating clinical service, research, and academic leadership to improve patient care and healthcare systems.

Research Interests

Dr. Taliercio’s research interests span dermatology, genetics, pediatrics, and biomedical informatics. Her work has focused on psoriasis, alopecia, neurocutaneous disorders such as neurofibromatosis and tuberous sclerosis complex, and patient-reported outcomes. She is also interested in leveraging electronic health records and healthcare information systems to improve clinical decision-making and healthcare quality. Earlier in her career, she contributed to the development of mortality registries and national health databases, demonstrating a strong interest in population-level health outcomes and system-wide improvements. Her interdisciplinary approach combines clinical insights with data analysis, aiming to translate research findings into practical interventions that enhance patient care. She is particularly interested in collaborative, cross-disciplinary projects that bridge clinical practice with informatics tools and public health strategies.

Research Skills

Dr. Taliercio brings a broad set of research skills honed through years of clinical and academic work. She has expertise in clinical research design, data extraction and analysis from electronic health records, and the development of clinical research informatics tools. She has authored and co-authored several peer-reviewed publications and presented her work at national and international conferences. Dr. Taliercio has experience in conducting patient-reported outcomes research, implementing quality indicators in healthcare systems, and contributing to the development of national health guidelines. She also has teaching experience, having helped develop courses in clinical research and epidemiology. Her multidisciplinary training has given her strong analytical abilities, a deep understanding of clinical workflows, and the ability to bridge gaps between clinical practice and research. She is skilled at working collaboratively with clinicians, researchers, and informaticians to bring projects from concept to implementation.

Awards and Honors

While Dr. Taliercio’s profile highlights a range of accomplishments, formal details on specific research awards or honors are not explicitly listed. However, her leadership roles and appointments—such as Assistant Professor, Co-director of the NF and TSC clinics, and Associate Program Director—reflect strong recognition by her institution and peers. Additionally, her international career trajectory, moving from national public health leadership in Argentina to academic medicine in the United States, speaks to her professional reputation and the trust placed in her abilities. Her contributions to national guidelines on Hansen’s Disease in Argentina and her involvement in major research projects in dermatology and informatics show that she is regarded as a valuable collaborator and leader in her fields. Documenting formal research awards, grants, or recognitions in future applications would further strengthen this section.

Conclusion

In summary, Dr. Vanina Taliercio is a dedicated and accomplished physician-scientist who has made significant contributions across multiple disciplines, including dermatology, genetics, pediatrics, and biomedical informatics. Her career is marked by a unique combination of clinical service, research productivity, and academic leadership. She has consistently demonstrated a commitment to improving patient care, advancing medical knowledge, and mentoring students and trainees. While her profile would benefit from additional emphasis on independent research leadership and formal recognitions, she is clearly a rising figure in her field with the potential for even greater impact. Dr. Taliercio is a strong candidate for research-focused awards and honors, reflecting her broad expertise, international experience, and dedication to translational medicine. Continued pursuit of large-scale research projects, funding opportunities, and international collaborations will further enhance her academic and professional profile.

Publications Top Notes

  • Title: Worth the Effort: Lessons for Discovery and Care From an Unusual Case of Gorlin Syndrome
    Journal: American Journal of Medical Genetics Part A
    Date: 2025-05-03
    DOI: 10.1002/ajmg.a.64108
    Contributors: V. Taliercio; J. Zhao; S. E. Boyden; R. Mao; P. Bayrak‐Toydemir; A. Pflaum; J. Palumbos; A. Andrews; E. E. Baldwin; C. Welt et al.

  • Title: Quality of Life Among Family of Patients with Atopic Dermatitis and Psoriasis
    Journal: International Journal of Behavioral Medicine
    Date: 2023-06
    DOI: 10.1007/s12529-022-10104-7
    Contributors: Ashley M. Snyder; Adelheid U. Brandenberger; Vanina L. Taliercio; Bianca E. Rich; Lisa B. Webber; Abram P. Beshay; Joshua E. Biber; Rachel Hess; Jamie L. W. Rhoads; Aaron M. Secrest

  • Title: Effects of Pain From Atopic Dermatitis: Interview and Focus Group Study With Patients and Their Families
    Journal: JMIR Dermatology
    Date: 2021-10-04
    DOI: 10.2196/29826
    Contributors: Ashley M. Snyder; Vanina L. Taliercio; Adelheid U. Brandenberger; Bianca E. Rich; Lisa B. Webber; Abram P. Beshay; Joshua E. Biber; Rachel Hess; Jamie L. W. Rhoads; Aaron M. Secrest

  • Title: Effects of Pain From Atopic Dermatitis: Interview and Focus Group Study With Patients and Their Families (Preprint)
    Date: 2021-04-22
    DOI: 10.2196/preprints.29826
    Contributors: Ashley M. Snyder; Vanina L. Taliercio; Adelheid U. Brandenberger; Bianca E. Rich; Lisa B. Webber; Abram P. Beshay; Joshua E. Biber; Rachel Hess; Jamie L. W. Rhoads; Aaron M. Secrest

Risa Yamada | Health Professions | Best Researcher Award

Ms. Risa Yamada | Health Professions | Best Researcher Award

Researcher from National Center of Neurology and Psychiatry, Japan

Risa Yamada is an esteemed Chief Researcher at the Department of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Japan. Her research primarily focuses on neuropsychopharmacology, epidemiology, and neurophysiology in patients with psychiatric disorders such as schizophrenia, mood disorders, and substance abuse. She is renowned for her pioneering work in the epidemiology of gambling disorders, exploring the impact of comorbid behavioral addiction. Her research has yielded significant insights into the effectiveness of serotonin-5-HT1A receptor partial agonists for cognitive enhancement in schizophrenia, with findings published in prestigious journals. Additionally, she is conducting cutting-edge research on transcranial photobiomodulation to ameliorate cognitive deficits in schizophrenia. Yamada has made notable contributions to the understanding of depression severity and the role of adverse childhood experiences in mood disorders. With a background in clinical psychology and neuropsychopharmacology, she is a rising leader in the field of psychiatric research.

Professional Profile

Education

Risa Yamada completed her medical education at the Jikei University School of Medicine, earning her Ph.D. in February 2023. Prior to this, she received a Bachelor of Science degree from Toho University in 2011 and a Master of Psychology from Teikyo University in 2018. Throughout her educational journey, she focused on the intersection of clinical psychology and psychiatry, particularly in understanding the neuropsychological aspects of psychiatric disorders. Her academic development laid a strong foundation for her subsequent research career. In addition to her medical degrees, Yamada holds certifications as a Clinical Psychologist (2019) and a Public Psychologist (2019), which further demonstrate her expertise and commitment to advancing psychological and psychiatric research. These educational qualifications, coupled with her practical research experience, allow Yamada to contribute significantly to the development of new treatment strategies for psychiatric conditions, particularly those related to cognitive dysfunction and behavioral addictions.

Professional Experience

Risa Yamada currently serves as the Chief Researcher at the Department of Preventive Intervention for Psychiatric Disorders at the National Institute of Mental Health, part of the National Center of Neurology and Psychiatry in Tokyo, Japan. She has been in this role since September 2021 and has been instrumental in leading research focused on cognitive impairments in psychiatric conditions such as schizophrenia. Yamada’s career began as a Research Associate in the Department of Mental Disorder Research at the National Center of Neurology and Psychiatry from 2018 to 2021, where she investigated depression severity and its links to adverse childhood experiences and coping styles. Prior to her current position, she conducted a doctoral research project at Jikei University, where she explored the relationship between gambling disorder and psychiatric conditions. Her extensive experience spans multiple research settings, with her work having a significant impact on clinical understanding and treatment development for various psychiatric conditions. Yamada’s role as a researcher and educator also extends to her involvement in several leading academic societies in psychiatry and neuropsychopharmacology.

Research Interests

Risa Yamada’s research interests lie at the intersection of clinical psychology, psychiatry, and neuropsychopharmacology. She is deeply engaged in studying the cognitive and neurophysiological aspects of psychiatric disorders, particularly schizophrenia, mood disorders, and behavioral addictions such as gambling disorders. Her work focuses on the use of neuropsychological methods to explore the biological and psychological underpinnings of these conditions, with a particular emphasis on cognitive impairment. One of her notable research projects involves studying the augmentation of cognitive function in schizophrenia using serotonin-5-HT1A receptor partial agonists, a promising avenue for improving psychotic symptoms and cognitive deficits. Additionally, Yamada is investigating the potential of transcranial photobiomodulation, a non-invasive brain stimulation technique, to address cognitive impairments in patients with schizophrenia. She also explores the relationship between adverse childhood experiences and mood disorders, with the goal of identifying effective biomarkers and treatments for negative valence in psychiatric conditions. Her research aims to advance both theoretical understanding and practical interventions for these prevalent and challenging mental health conditions.

Research Skills

Risa Yamada possesses a diverse and advanced skill set in clinical research, particularly in the fields of neuropsychopharmacology, epidemiology, and neurophysiology. She is proficient in conducting meta-analyses and cross-sectional studies, particularly related to psychiatric disorders and cognitive dysfunction. Her expertise in neuropsychological methods allows her to investigate complex interactions between psychological traits and psychiatric conditions. Yamada is skilled in using clinical scales and neurophysiological tools, such as skin conductivity measures, to assess psychological traits like interoception and alexithymia in relation to psychiatric conditions. Furthermore, she has experience in neuroimaging techniques, including the use of transcranial photobiomodulation for brain stimulation. Yamada’s work with behavioral addiction, particularly gambling disorders, demonstrates her ability to apply epidemiological methods to mental health research. She is also adept at analyzing large-scale clinical data sets and using statistical models to explore the relationship between psychiatric symptoms and demographic variables. These research skills enable her to lead impactful studies that contribute both to the scientific community and to practical applications in the treatment of psychiatric disorders.

Awards and Honors

Risa Yamada has received recognition for her contributions to psychiatric research, particularly in the areas of neuropsychopharmacology and behavioral addiction. She has been awarded several academic honors, including recognition for her groundbreaking research on gambling disorders, which was the first of its kind in Japan. Her work on cognitive enhancement therapies for schizophrenia has been published in high-impact journals, earning her a reputation as a leader in the field. While she has not yet received large-scale awards, her growing recognition within the academic community and her role as Chief Researcher at the National Institute of Mental Health reflect her increasing influence. Yamada’s contributions to psychiatric research have been acknowledged through invitations to present her findings at prestigious international conferences. She is also a member of several leading professional societies, including the Collegium Internationale Neuro-Psychopharmacologicum and the Japanese Society of Neuropsychopharmacology, further solidifying her status as a respected researcher.

Conclusion

Risa Yamada is a highly promising and accomplished researcher in the field of psychiatry, with a focus on neuropsychopharmacology, neurophysiology, and epidemiology. Her work has already made a significant impact, particularly in the understanding of cognitive dysfunction in schizophrenia and gambling disorders. With a robust educational background and extensive professional experience, Yamada is well-positioned to continue contributing to the advancement of psychiatric research. Her innovative approach to non-invasive brain stimulation, alongside her focus on biomarkers for psychiatric conditions, highlights her potential for further breakthroughs. While her research is primarily centered on schizophrenia and mood disorders, expanding her focus to other psychiatric conditions would enhance the breadth of her contributions. With continued growth in international collaboration and further emphasis on translational research, Yamada has the potential to make a lasting impact on both clinical practice and scientific understanding in the field of psychiatry.

Publications Top Notes

  • Clinical Significance of Psychiatric Comorbidities Among Outpatients With Gambling Disorder in Japan: A 12-Month Follow-Up Study
    Authors: Yamada, R., Stickley, A., Shigeta, M., Miyata, H.
    Year: 2025

  • Semantic memory disorganization linked to social functioning in patients with schizophrenia
    Authors: Wada, A., Sumiyoshi, C., Yoshimura, N., Hashimoto, R., Matsumoto, J., Stickley, A., Yamada, Y., Kikuchi, A., Kubota, R., Matsui, M., Nakachi, K., Fujimaki, C., Adachi, L., Yamada, R., Sumiyoshi, T.
    Year: 2025

  • Autistic trait severity in early schizophrenia: Role in subjective quality of life and social functioning
    Authors: Wada, A., Yamada, R., Yamada, Y., Sumiyoshi, C., Hashimoto, R., Matsumoto, J., Kikuchi, A., Kubota, R., Matsui, M., Nakachi, K., Fujimaki, C., Adachi, L., Stickley, A., Yoshimura, N., Sumiyoshi, T.
    Year: 2025

  • Problematic gambling and psychotic-like experiences: Findings from Japan
    Authors: Stickley, A., Shirama, A., Yamada, R., Sumiyoshi, T.
    Year: 2024

  • Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis
    Authors: Yamada, R., Wada, A., Stickley, A., Yokoi, Y., Sumiyoshi, T.
    Year: 2023

  • Effect of 5-HT1A Receptor Partial Agonists of the Azapirone Class as an Add-On Therapy on Psychopathology and Cognition in Schizophrenia: A Systematic Review and Meta-Analysis
    Authors: Yamada, R., Wada, A., Stickley, A., Yokoi, Y., Sumiyoshi, T.
    Year: 2023

  • Prevalence and Clinical Significance of Psychiatric Comorbidities With Gambling Disorder in 12 Clinical Settings in Japan
    Authors: Yamada, R., Miyashita, K., Hashimoto, T. M., et al.
    Year: 2023

  • Discrepancy between Clinician-rated and Self-reported Depression Severity is Associated with Adverse Childhood Experience, Autistic-like Traits, and Coping Styles in Mood Disorders
    Authors: Yamada, R., Fujii, T., Hattori, K., et al.
    Year: 2023

  • The relationship between severity of drug problems and perceived interdependence of drug use and sexual intercourse among adult males in drug addiction rehabilitation centers in Japan
    Authors: Yamada, R., Shimane, T., Kondo, A., Yonezawa, M., Matsumoto, T.
    Year: 2021